2018-2023 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Report

2018-2023 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Report

Category

Chemicals and Materials

Published Date

6th Jun 2018

Pages

130

Choose License

Final Price

This report covers the present scenario (with the base year being 2017) and the growth prospects of global 23-Valent Pneumococcal Polysaccharide Vaccine market for 2018-2023.

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.
The second place is EU, following North America with production market share of 15% and sales market share nearly 20% in 2015.China is another important market of 23-Valent Pneumococcal Polysaccharide Vaccine, enjoying 10% production market share and 15% sales market share in 2015.
Over the next five years, this report projects that 23-Valent Pneumococcal Polysaccharide Vaccine will register a 16.3% CAGR in terms of revenue, reach US$ 3830 million by 2023, from US$ 1550 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions.

To calculate the market size, this report considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Single Dose Vial
Pre-filled Syringe
Segmentation by application:
For Children (2-10)
For Person (10-64)
For The Old (≥65)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
MSD
Sanofipasteur
CDIBP
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global 23-Valent Pneumococcal Polysaccharide Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of 23-Valent Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.
Focuses on the key global 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the 23-Valent Pneumococcal Polysaccharide Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of 23-Valent Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2018-2023 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2013-2023
2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2013-2018)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2013-2018)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2013-2018)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (2-10)
2.4.2 For Person (10-64)
2.4.3 For The Old (≥65)
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value and Market Share by Application (2013-2018)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2013-2018)

3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Players
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Players
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Players (2016-2018)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Players (2016-2018)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Players
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Players (2016-2018)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Players (2016-2018)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Players
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
4.1 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Regions
4.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth

5 Americas
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Countries
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Countries
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer

11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2023)
11.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions
11.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions (2018-2023)
11.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
11.8 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application

12 Key Players Analysis
12.1 MSD
12.1.1 Company Details
12.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 MSD News
12.2 Sanofipasteur
12.2.1 Company Details
12.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Sanofipasteur News
12.3 CDIBP
12.3.1 Company Details
12.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 CDIBP News
...

13 Research Findings and Conclusion
List of Tables and Figures

Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Product Specifications of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure Market Research Methodology
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate 2013-2023 (K Dose)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth Rate 2013-2023 ($ Millions)
Table 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Single Dose Vial
Table Major Players of Single Dose Vial
Figure Product Picture of Pre-filled Syringe
Table Major Players of Pre-filled Syringe
Table Global Consumption Sales by Type (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2013-2018) ($ million)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Type (2013-2018) ($ Millions)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Type (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2013-2018)
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2013-2018) (K Dose)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2013-2018) ($ Millions)
Figure Global For Children (2-10) YoY Growth ($ Millions)
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2013-2018) (K Dose)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2013-2018) ($ Millions)
Figure Global For Person (10-64) YoY Growth ($ Millions)
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (≥65)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (≥65) (2013-2018) (K Dose)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (≥65) (2013-2018) ($ Millions)
Figure Global For The Old (≥65) YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Application (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Application (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Application (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Players (2016-2018) (K Dose)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Players (2016-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Players in 2016
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Players in 2017
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Players (2016-2018) ($ Millions)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Players (2016-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Players in 2016
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Players in 2017
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Players (2016-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Players in 2017
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area by Players
Table Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions 2013-2018 (K Dose)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions 2013-2018
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions 2013-2018
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Regions 2013-2018 ($ Millions)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions 2013-2018
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions 2013-2018
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2013-2018 (K Dose)
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value 2013-2018 ($ Millions)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2013-2018 (K Dose)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value 2013-2018 ($ Millions)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2013-2018 (K Dose)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value 2013-2018 ($ Millions)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2013-2018 (K Dose)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value 2013-2018 ($ Millions)
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018) (K Dose)
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2013-2018)
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2017
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018) ($ Millions)
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2013-2018)
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2017
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2013-2018) (K Dose)
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2013-2018)
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2017
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2013-2018) (K Dose)
Table Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2017
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018) (K Dose)
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2013-2018)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2017
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018) ($ Millions)
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2013-2018)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2017
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2013-2018) (K Dose)
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2013-2018)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2017
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2013-2018) (K Dose)
Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2017
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018) (K Dose)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2017
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018) ($ Millions)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2017
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2013-2018) (K Dose)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2017
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2013-2018) (K Dose)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2017
Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2013-2018) (K Dose)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2017
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2013-2018)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2017
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2013-2018) (K Dose)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2017
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2013-2018) (K Dose)
Table Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2017
Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Israel 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Israel 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2013-2018 (K Dose)
Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2013-2018 ($ Millions)
Table 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate Forecast (2018-2023) (K Dose)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Countries (2018-2023) (K Dose)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Forecast by Regions
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Countries (2018-2023) ($ Millions)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Regions
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Korea 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Israel 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Israel 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2018-2023 (K Dose)
Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Value 2018-2023 ($ Millions)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Type (2018-2023) (K Dose)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share Forecast by Type (2018-2023)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Type (2018-2023) ($ Millions)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Type (2018-2023)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2018-2023) (K Dose)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share Forecast by Application (2018-2023)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Application (2018-2023) ($ Millions)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Application (2018-2023)
Table MSD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Market Share (2016-2018)
Table Sanofipasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Market Share (2016-2018)
Table CDIBP Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Market Share (2016-2018)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us